ABSTRACT
INTRODUCTION
WHO defines "Palliative care as an approach that improves the quality of life of patients and their families facing the problem associated with life-threatening illness, through the prevention and relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual" [1] . Similar to cancer treatment, a multidisciplinary team encompassing physicians, nurses, social workers and many others is required to provide comprehensive palliative care. Palliative care, which initially started as hospice care in the 1970s, has now undergone rapid growth to become a sub-speciality of medicine.
Pain is one of the most common symptoms observed in cancer patients presenting to palliative care clinic. Most cancer patients experience some degree of pain, especially in advanced stages, precluding satisfactory quality of life. A systematic review found pain reported in 35-96% of cancer patients. The prevalence of pain is about 70% in advanced stage [2] . Cancer pain is treated following the WHO analgesic ladder [3] . WHO analgesic ladder is a three-step approach to the management of cancer pain. Despite the widespread recognition of guidelines for the treatment of cancer pain and increase in opioid consumption, a significant number of patients are still experiencing and suffering from cancer pain. Globally, 80% of the cancer population receive inadequate or no pain medication [4, 5] .
A Palliative care clinic had been started in our regional cancer centre in 2012. In this article, we present a review of the medical records of the patients who got registered in our palliative care clinic, the status of their pain during initial and subsequent visits and detailed information on the use of strong opioids in our palliative clinic. This audit may help in the modification of existing and formulation of new policies in the delivery of palliative care.
METHODS
All patients registered in our palliative care clinic from 2012 to 2015 were taken into this retrospective cross-sectional study. A palliative care registry form was completed for each patient entering into palliative care clinic by a health care professional. The form contained information on demographics, age, gender, diagnosis, the presence of distant metastases. The following data were also obtained from the registry and follow-up forms: symptoms reported by the patient, pain scores, pain medications and their doses. All data are descriptive in character and described using frequency tables with counts and percentages.
RESULTS
The palliative care records of 2142 patients who got registered in our regional cancer centrewere reviewed. The patient characteristics regarding age, sex, primary site, stage and metastases are shown in Table 1 . Out of 2142 patients, 52% were males. The median age was 55. The majority of patients were in the age group of 40-60 years. Figure 1 shows the age distribution of the patients. About 98.5% of patients had malignant disease. The most common primary site was head and neck (32%) followed by gastrointestinal tract cancers (19%). Bones (52%) and lungs (32%) were the most common sites of distant metastases. Table 2 shows the various modalities of treatment received by the patients registered in our palliative care unit. Nearly one-half of the patients received only best supportive care. About 23% of patients received only palliative radiotherapy, and 12% of patients received only chemotherapy. The most common symptom reported by patients attending our palliative care clinic is pain (92%). Other major symptoms include insomnia (76%), loss of appetite (70%), weight loss (72%) and constipation (69%) as shown in Table 3 .
The prevalence of pain is 92.8% in our cancer patients. About 40% of patients with pain had the pain of severe intensity (pain score of 7-10 on the numerical rating scale) at initial presentation to palliative care clinic. Patients with mild to moderate pain were prescribed paracetamol, non-steroidal anti-inflammatory drugs (NSAIDS), weak opioids (tramadol) and other adjuvant analgesics like tricyclic antidepressants if required. Patients with severe pain received morphine. About 65% of the patients with severe pain had a response to treatment withmorphine during their first follow-up to palliative care unit after initial registration. At the time of this study, there were 571 patients receiving morphine for severe pain; the rest of the patients with severe pain were either dead or lost to followup. Figure 2 shows the distribution of daily doses of morphine for these patients. The majority of patients received morphine doses ranging from 30-60 mg. The average overall pain score of the patients per visit decreased from around 7 to 4 at a median follow-up of ten months as depicted in figure 3 .
DISCUSSION
Pain is defined as an "unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage" [6] . Pain is influenced by many factors including emotional, cognitive and spiritual. It is not possible definitively to identify whether the pain that occurs is associated with actual tissue damage or not [7] .
According to this study, the prevalence of pain in patients referred to our palliative unit is 92.8%, and nearly 40% of the patients had the pain of severe intensity by numerical rating scale [NRS score of 7-10]. Overall, the literature suggests that pain is one of the most feared symptoms in cancer patients and there are wide variations in reported prevalence [8] . A systematic review showed that the prevalence of pain in cancer patients ranges from 35-96% [2, 9] . The possible cause for this significant variation in prevalence is that these studies are conducted in different sets of the population and variedsettings, and so, it is hard to generalise these findings. Moreover, there is no standard method available to assess whether a patient has pain or not and its severity [2, 10, 11] .
Our study revealed that the majority of patients with severe pain were treated with only NSAIDS and weak opioids at the time of presentation to palliative care unit; only a few patients received strong opioids like morphine; this shows that the primary physicians have inadequately treated pain. The literature also confirms our findings that pain is still prevalent in cancer patients and it has been inadequately treated. In a study by Cleeland et al. [5] , about 42% of the patients with pain did not receive adequate pain medications. The IASP Task Force on cancer pain survey also demonstrated the inadequacy of cancer pain treatment [4] . The possible reasons for high prevalence, and poor cancer pain treatment by the primary physicians could be the opiophobia, the lack of adequate education and training for the prescription of strong opioids, or some patient related barriers [12, 13] .
The World Health Organisation [WHO] approach is a three-step approach to the management of cancer pain. According to this method, patients with mild cancer pain are treated with paracetamol and NSAIDs; patients with moderate pain and mild pain refractory to NSAIDs are treated with weak opioids like tramadol; patients with severe pain or moderate pain not responding to weak opioids are treated with strong opioids like morphine. Adjuvant analgesics like corticosteroids, tricyclic antidepressants are prescribed when required. Literature analysis shows that patients with severe pain started on strong opioids as first-line therapy had better pain relief and required fewer changes in treatment. Our results are similar as reported in the literature. In our study, we found that about 60% of patients with severe pain had adequate pain relief after starting morphine [14, 15] .
The limitations of this study include those that are observed in any retrospective study. The health care personnel makes the assessment of pain in this study; usually, observer assessments underestimate pain intensity. Moreover, the study may not reflect the actual prevalence of severe pain in the regional cancer centre since all patients with severe pain are not referred to the palliative care unit.
In conclusion, thus, there is a high prevalence of pain in cancer patients presenting to our palliative care unit. Patients with severe pain receive little or no opioid medication at all by the primary care doctors probably due to the lack of adequate education and training to the primary oncologists and residents regarding prescription of strong opioids.
ACKNOWLEDGMENT
We would like to thank -JivDaya Foundation, Dallas, Texas, USA for their support in Palliative Care. 
